TitleProduct

Tirzepatide

  • Price:

    Negotiable

  • minimum:

  • Total supply:

  • Delivery term:

    The date of payment from buyers deliver within days

  • seat:

    Beijing

  • Validity to:

    Long-term effective

  • Last update:

    2026-03-07 22:13

  • Browse the number:

    0

Send an inquiries

Company Profile

Shaanxi Lymall Bpanda Tech Co., Ltd.

By certification [File Integrity]

Contact:ydoqodoh(Mr.)  

Email:

Telephone:

Phone:

Area:Beijing

Address:Room 1502, Building B, Zhongdeng Wenjing Mansion, Weiyang District, Xi'an City, Shaanxi Province

Website: http://816b274b.longshizhaoming.com/

PRODUCT DETAILS
As the world's first GIP/GLP-1 dual receptor agonist pharmaceutical raw material, Tirzepatide is crafted via advanced synthesis and purification, with =95% bioavail ability. Unlike single-target metabolic drugs, its core edge is dual-receptor co-activation, breaking single-target GLP-1 efficacy limits to synergize weight loss and blood glucose control, with longer-lasting results and lower blood glucose fluctuation risk.
link:http://www.lymallpanda.com